Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Overweight smokers have worse hair loss.

Hair thickness matters more than density for baldness in Japanese men over 25.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

Abnormal cuticle and hair shaft medulla cause hair loss in androgenetic alopecia; sonography helps diagnose and manage it.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Finasteride side effects in young men may be linked to specific gene variations.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Young adults with hair loss face higher risk of stiff arteries.